A detailed history of Parvin Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Parvin Asset Management, LLC holds 5,595 shares of AMGN stock, worth $1.67 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares
5,595
Previous 5,634 0.69%
Holding current value
$1.67 Million
Previous $1.76 Billion 11.0%
% of portfolio
1.57%
Previous 1.92%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$262.28 - $309.85 $10,228 - $12,084
-39 Reduced 0.69%
5,595 $1.56 Billion
Q1 2025

May 15, 2025

BUY
$258.59 - $327.36 $12,670 - $16,040
49 Added 0.88%
5,634 $1.76 Billion
Q4 2024

Feb 14, 2025

BUY
$258.78 - $328.31 $1.45 Million - $1.83 Million
5,585 New
5,585 $1.46 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $160B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Parvin Asset Management, LLC Portfolio

Follow Parvin Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parvin Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parvin Asset Management, LLC with notifications on news.